These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 34371377)

  • 1. Correction: Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action.
    Tchesnokov EP; Gordon CJ; Woolner E; Kocincova D; Perry JK; Feng JY; Porter DP; Götte M
    J Biol Chem; 2021 Aug; 297(2):101048. PubMed ID: 34371377
    [No Abstract]   [Full Text] [Related]  

  • 2. Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action.
    Tchesnokov EP; Gordon CJ; Woolner E; Kocinkova D; Perry JK; Feng JY; Porter DP; Götte M
    J Biol Chem; 2020 Nov; 295(47):16156-16165. PubMed ID: 32967965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir.
    Yin W; Mao C; Luan X; Shen DD; Shen Q; Su H; Wang X; Zhou F; Zhao W; Gao M; Chang S; Xie YC; Tian G; Jiang HW; Tao SC; Shen J; Jiang Y; Jiang H; Xu Y; Zhang S; Zhang Y; Xu HE
    Science; 2020 Jun; 368(6498):1499-1504. PubMed ID: 32358203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus.
    Gordon CJ; Tchesnokov EP; Feng JY; Porter DP; Götte M
    J Biol Chem; 2020 Apr; 295(15):4773-4779. PubMed ID: 32094225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir.
    Tchesnokov EP; Feng JY; Porter DP; Götte M
    Viruses; 2019 Apr; 11(4):. PubMed ID: 30987343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.
    Gordon CJ; Tchesnokov EP; Woolner E; Perry JK; Feng JY; Porter DP; Götte M
    J Biol Chem; 2020 May; 295(20):6785-6797. PubMed ID: 32284326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revealing the Inhibition Mechanism of RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2 by Remdesivir and Nucleotide Analogues: A Molecular Dynamics Simulation Study.
    Wakchaure PD; Ghosh S; Ganguly B
    J Phys Chem B; 2020 Nov; 124(47):10641-10652. PubMed ID: 33190493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Antiviral Activity of Remdesivir and Anti-HIV Nucleoside Analogs Against Human Coronavirus 229E (HCoV-229E).
    Parang K; El-Sayed NS; Kazeminy AJ; Tiwari RK
    Molecules; 2020 May; 25(10):. PubMed ID: 32429580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase.
    Wang Q; Wu J; Wang H; Gao Y; Liu Q; Mu A; Ji W; Yan L; Zhu Y; Zhu C; Fang X; Yang X; Huang Y; Gao H; Liu F; Ge J; Sun Q; Yang X; Xu W; Liu Z; Yang H; Lou Z; Jiang B; Guddat LW; Gong P; Rao Z
    Cell; 2020 Jul; 182(2):417-428.e13. PubMed ID: 32526208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac Adverse Events With Remdesivir in COVID-19 Infection.
    Gupta AK; Parker BM; Priyadarshi V; Parker J
    Cureus; 2020 Oct; 12(10):e11132. PubMed ID: 33240723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Halting coronavirus polymerase.
    Kirchdoerfer RN
    J Biol Chem; 2020 Apr; 295(15):4780-4781. PubMed ID: 32277065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. THE PECULIARITY OF COVID- 19 GENOME AND THE CORONAVIRUS RNA TRANSLATION PROCESS AS APOTENTIAL TARGET FOR ETIOTROPIC MEDICATIONSWITH ADENINE AND OTHER NUCLEOTIDE ANALOGUES (REVIEW).
    Ratiani L; Gegechkory S; Machavariani K; Shotadze T; Sanikidze T; Intskirveli N
    Georgian Med News; 2021 Jan; (310):119-124. PubMed ID: 33658420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The strand-biased transcription of SARS-CoV-2 and unbalanced inhibition by remdesivir.
    Zhao Y; Sun J; Li Y; Li Z; Xie Y; Feng R; Zhao J; Hu Y
    iScience; 2021 Aug; 24(8):102857. PubMed ID: 34278249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Characterization of a Human Coronavirus 229E Nonstructural Protein 8-Associated RNA 3'-Terminal Adenylyltransferase Activity.
    Tvarogová J; Madhugiri R; Bylapudi G; Ferguson LJ; Karl N; Ziebuhr J
    J Virol; 2019 Jun; 93(12):. PubMed ID: 30918070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advances Towards Drug Design Targeting the Protease of 2019 Novel Coronavirus (2019-nCoV).
    Bano S; Hameed A; Al-Rashida M; Iftikhar S; Iqbal J
    Curr Med Chem; 2021; 28(22):4484-4498. PubMed ID: 33109027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Basis of SARS-CoV-2 Polymerase Inhibition by Favipiravir.
    Peng Q; Peng R; Yuan B; Wang M; Zhao J; Fu L; Qi J; Shi Y
    Innovation (Camb); 2021 Feb; 2(1):100080. PubMed ID: 33521757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of replicating SARS-CoV-2 polymerase.
    Hillen HS; Kokic G; Farnung L; Dienemann C; Tegunov D; Cramer P
    Nature; 2020 Aug; 584(7819):154-156. PubMed ID: 32438371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the RNA-dependent RNA polymerase from COVID-19 virus.
    Gao Y; Yan L; Huang Y; Liu F; Zhao Y; Cao L; Wang T; Sun Q; Ming Z; Zhang L; Ge J; Zheng L; Zhang Y; Wang H; Zhu Y; Zhu C; Hu T; Hua T; Zhang B; Yang X; Li J; Yang H; Liu Z; Xu W; Guddat LW; Wang Q; Lou Z; Rao Z
    Science; 2020 May; 368(6492):779-782. PubMed ID: 32277040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of rat liver RNA polymerases by action of the methylating agents dimethylnitrosamine in vivo and methyl methanesulfonate in vitro.
    Herzog J; Farber JL
    Cancer Res; 1976 May; 36(5):1761-70. PubMed ID: 178432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice.
    Pruijssers AJ; George AS; Schäfer A; Leist SR; Gralinksi LE; Dinnon KH; Yount BL; Agostini ML; Stevens LJ; Chappell JD; Lu X; Hughes TM; Gully K; Martinez DR; Brown AJ; Graham RL; Perry JK; Du Pont V; Pitts J; Ma B; Babusis D; Murakami E; Feng JY; Bilello JP; Porter DP; Cihlar T; Baric RS; Denison MR; Sheahan TP
    Cell Rep; 2020 Jul; 32(3):107940. PubMed ID: 32668216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.